Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Victor J Jimenez Zepeda
Observed names:
V J Zepeda,
Victor Jimenez Zepeda
Observed institution:
Mayo Clinic in Arizona
OpenAlex ID:
A5035538533
Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma
2008
·
H Paripati
, A K Stewart
, et al.
·
Leukemia
·
130
Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance
2019
·
Holly Lee
, Peter Duggan
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
6
A Phase II Trial Comparison of Once Versus Twice Weekly Bortezomib in CYBORD Chemotherapy for Newly Diagnosed Myeloma: Identical High Response Rates and Less Toxicity.
2009
·
Craig B. Reeder
, Donna E. Reece
, et al.
·
Blood
·
5
Loss of p53 Is a Marker of Progression in Plasma Cell Neoplasias and Is a Negative Prognostic Factor in Relapsed Disease.
2008
·
Soledad Molnar
, Victor J Jimenez Zepeda
, et al.
·
Blood
·
4
Show more works
View as search
Works count:
4
Citation count:
145
H-index:
4
I10-index:
1
Year
Topic
Type
